甘油三酯葡萄糖指数与冠心病关系的研究进展

摘要/Abstract

摘要： 冠状动脉粥样硬化性心脏病（coronary athero-sclerotic heart disease ,CHD）是导致我国居民死亡和过早死亡的首要原因,且每年因CHD死亡的人数仍呈持续攀升的趋势。因此,尽早识别CHD高危人群并及时实施预防与干预措施,是减轻疾病负担的关键所在。当前心脏病防治领域高度关注代谢紊乱与CHD发生发展之间的相关性研究。已有研究表明,胰岛素抵抗（insulin resistance, IR）是推动CHD发生发展的关键因素之一,甘油三酯葡萄糖指数（triglyceride-glucose index ,TyG指数）作为可替代IR的生物标志物,因其在临床中易于获取,逐渐被视作预测CHD发生发展的潜在生物标志物,受到越来越多关注。本文围绕TyG指数指数与冠心病发生发展相关性的研究进展作此综述。

关键词: 冠心病, 甘油三酯葡萄糖指数, 胰岛素抵抗, 综述

刘耀平, 赵明才, 敬梦彦. 甘油三酯葡萄糖指数与冠心病关系的研究进展[J]. 心血管病防治知识, 2026, 16(4): 141-144.

参考文献

[1] 中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2022概要[J].中国循环杂志,2023,38(6):583-612.DOI:10.3969/j.issn.1000-3614.2023.06.001.
[2] 国家卫生健康委员会. 中国卫生健康统计年鉴 2021[M]. 北京 : 中国协和医科大学出版社 , 2021.
[3] Hou XZ, Lv YF, Li YS, et al.Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: longitudinal cohort study[J]. Cardiovasc Diabetol, 2024,23(1):86.
[4] da Silva A, Caldas APS, Hermsdorff HHM, et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care[J]. Cardiovasc Diabetol, 2019,18(1):89.
[5] Luo E, Wang D, Yan G, et al.High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention[J]. Cardiovasc Diabetol, 2019,18(1):150.
[6] Wang S, Zhang X, Keerman M, et al.Impact of the baseline insulin resistance surrogates and their longitudinal trajectories on cardiovascular disease (coronary heart disease and stroke): a prospective cohort study in rural China[J]. Front Endocrinol (Lausanne), 2023,14:1259062.
[7] Wu Z, Liu L, Wang W, et al.Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study[J]. Cardiovasc Diabetol, 2022,21(1):142.
[8] Laws A, Reaven GM.Insulin resistance and risk factors for coronary heart disease[J]. Baillieres Clin Endocrinol Metab,1993,7(4):1063-78.
[9] Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al.The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp[J]. J Clin Endocrinol Metab, 2010,95(7):3347-51.
[10] Liang S, Wang C, Zhang J, et al.Triglyceride-glucose index and coronary artery disease: a systematic review and meta-analysis of risk, severity, and prognosis[J]. Cardiovasc Diabetol, 2023,22(1):170.
[11] Wang X, Xu W, Song Q, et al.Association between the triglyceride-glucose index and severity of coronary artery disease[J]. Cardiovasc Diabetol, 2022,21(1):168.
[12] Cui C, Liu L, Zhang T, et al.Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study[J]. Cardiovasc Diabetol, 2023,22(1):325.
[13] Huang R, Wang Z, Chen J, et al.Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure[J]. Cardiovasc Diabetol, 2022,21(1):88.
[14] Khalaji A, Behnoush AH, Khanmohammadi S, et al. Triglyceride-glucose index and heart failure: a systematic review and meta-analysis[J]. Cardiovasc Diabetol, 2023 Sep 7;22(1):244.
[15] Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events[J]. Eur J Clin Invest, 2016,46(2):189-97.
[16] Dzau VJ. Atherosclerosis and hypertension: mechanisms and interrelationships[J]. J Cardiovasc Pharmacol, 1990;15 Suppl 5:S59-64.
[17] 中国医疗保健国际交流促进会心血管病学分会. 高血压合并冠心病患者血压管理中国专家共识[J]. 中华医学杂志,2022,102(10):717-728.
[18] Zheng R, Mao Y.Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study[J]. Lipids Health Dis, 2017,16(1):175.
[19] Zhao Y, Yang X, Wu Y, et al.Association of triglyceride-glucose index and its 6-year change with risk of hypertension: A prospective cohort study[J]. Nutr Metab Cardiovasc Dis, 2023,33(3):568-576.
[20] Liu Y, Zhu B, Zhou W, et al.Triglyceride-glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension[J]. Cardiovasc Diabetol, 2023,22(1):133.
[21] Tao S, Yu L, Li J, et al.Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension[J]. Cardiovasc Diabetol, 2023,22(1):305.
[22] Ma CY, Luo YM, Zhang TY, et al.Predicting coronary heart disease in Chinese diabetics using machine learning[J]. Comput Biol Med, 2024,169:107952.
[23] Kumar A, Gangwar R, Zargar AA, Kumar R, Sharma A.Prevalence of Diabetes in India: A Review of IDF Diabetes Atlas 10th Edition[J]. Curr Diabetes Rev, 2024;20(1):e130423215752.
[24] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志,2021,13(4):315-409.
[25] 葛旭红,胡洁怡,白云瑞,等. 三酰甘油-葡萄糖指数及其衍生指数与2型糖尿病发病关系的巢式病例对照研究[J]. 中国全科医学,2023,26(12):1456-1462.
[26] Li X, Sun M, Yang Y, et al.Predictive Effect of Triglyceride Glucose-Related Parameters, Obesity Indices, and Lipid Ratios for Diabetes in a Chinese Population: A Prospective Cohort Study[J]. Front Endocrinol (Lausanne), 2022,13:862919.
[27] Liu C, Liang D, Xiao K, Xie L.Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes[J]. Cardiovasc Diabetol, 2024,23(1):171.
[28] Zhang Q, Xiao S, Jiao X, Shen Y.The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from 2001-2018[J]. Cardiovasc Diabetol, 2023,22(1):279.
[29] 李青,刘自州,孙晓楠,等. 肥胖的病因、流行病学与心血管风险因素[J]. 临床内科杂志,2025,42(1):1-4.
[30] Kelly T, Yang W, Chen CS, Reynolds K, He J.Global burden of obesity in 2005 and projections to 2030[J]. Int J Obes (Lond), 2008,32(9):1431-7.
[31] 俞匀,唐伟. 新诊断2型糖尿病患者甘油三酯-葡萄糖指数及相关指标与内脏型肥胖相关性的研究[J]. 中国糖尿病杂志,2025,33(2):119-124.
[32] Tian X, Chen S, Wang P, et al.Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study[J]. Cardiovasc Diabetol, 2022,21(1):289.
[33] 龙珊,刘兴德,李甜甜,等. 冠心病患者经皮冠状动脉介入治疗术后合并焦虑抑郁机制及治疗的研究进展[J]. 实用医学杂志,2023,39(21):2850-2856.
[34] Li J, Dong Z, Wu H, et al.The triglyceride-glucose index is associated with atherosclerosis in patients with symptomatic coronary artery disease, regardless of diabetes mellitus and hyperlipidaemia[J]. Cardiovasc Diabetol, 2023,22(1):224.
[35] Zhao S, Wang Z, Qing P, et al.Comprehensive analysis of the association between triglyceride-glucose index and coronary artery disease severity across different glucose metabolism states: a large-scale cross-sectional study from an Asian cohort[J]. Cardiovasc Diabetol, 2024,23(1):251.
[36] 严语, 毛霄鹏. 三酰甘油-葡萄糖指数与冠心病病人冠状动脉病变严重程度的相关性分析[J]. 蚌埠医科大学学报, 2023, 48(2): 195-199.
[37] Lin Z, He J, Song C, et al.Association of triglyceride-glucose index with adverse cardiovascular events in patients with established coronary artery disease according to different inflammatory status[J]. Nutr Metab Cardiovasc Dis, 2024,34(9):2124-2133.
[38] Wu Z, Liu L, Wang W, et al.Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study[J]. Cardiovasc Diabetol, 2022,21(1):142.
[39] Siverio-Morales O, Mora-Fernández C, Hernández-Carballo C, et al.Predictive value of triglyceride-glucose index for the evaluation of coronary artery disease severity and occurrence of major adverse cardiovascular events[J]. Am J Physiol Heart Circ Physiol, 2025,328(1):H14-H20.
[40] Li M, Cui X, Zhang Y, et al.The relative and combined ability of triglyceride-glucose index and stress hyperglycemia ratio to predict major adverse cardio-cerebral events in patients with multivessel coronary artery disease[J]. Diabetol Metab Syndr, 2024,16(1):234.
[41] Simental-Mendía LE, Hernández-Ronquillo G, Gómez-Díaz R, Rodríguez-Morán M, Guerrero-Romero F.The triglycerides and glucose index is associated with cardiovascular risk factors in normal-weight children and adolescent[J]s. Pediatr Res, 2017,82(6):920-925.
[42] 田露,汪驰,赵茂翔,等. 甘油三酯-葡萄糖指数与老年高血压合并冠心病患者全因死亡的关联研究[J]. 中华检验医学杂志,2024,47(5):506-513.